Get the Stockscreener App
1.57
5.95%
-0.11
China Pharma Holdings Inc. stock is traded at $1.57, with a volume of 20,092.
It is down -5.95% in the last 24 hours and down -17.28% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$1.68
Open:
$1.68
24h Volume:
20,092
Relative Volume:
0.25
Market Cap:
$5.09M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-4.6726
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
-25.12%
1M Performance:
-17.28%
6M Performance:
-21.98%
1Y Performance:
-43.37%
1-Day Range:
$1.56
$1.68
1-Week Range:
$1.56
$2.3095
52-Week Range:
$1.20
$3.35
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.56 | 6.88M | 5.54M | -4.74M | -750.60K | -0.336 |
|
HLN
Haleon Plc Adr
|
11.14 | 50.54B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
171.38 | 74.02B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.86 | 4.22M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.98 | 45.82B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.30 | 20.31B | 16.54B | -1.64B | 749.00M | -1.45 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
CPHI Stock Analysis: Current Position and Dry Eye Device Catalyst Update - Blockchain News
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
Jane Street Group LLC Has $508,000 Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Deutsche Bank AG Increases Stake in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - Defense World
$CPHI Stock Surges on Unusual Volume: Real-Time Trading Analysis and Crypto Market Impact - Blockchain News
Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews
Drug Discovery Services Market 2025–2032: Value Chain Analysis and Key Growth Contributors - newstrail.com
$CPHI Stock Surges with Unusual Volume: Crypto Market Implications and Real-Time Analysis - Blockchain News
China Pharma (NYSE:CPHI) Stock Rating Upgraded by StockNews.com - Defense World
HSI Up 348 pts; HSTI Up 60 pts; CSPC PHARMA Up over 6%; BYD COMPANY, CHINA MOBILE, HSBC HOLDINGS, BOC HONG KONG, 3SBIO Hit New Highs; Market Turnover Rises - AASTOCKS.com
Royalty Pharma plc (NASDAQ:RPRX) Holdings Trimmed by Captrust Financial Advisors - Defense World
Inozyme Pharma, Emerson Electric, Stanley Black & Decker - TradingView
Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices - Yahoo Finance
Trump tariffs live updates: Trump hails 'very good progress' as US-China talks continue - Yahoo Finance
Trump tariffs live updates: Trump floats slashing China tariffs to 80% with 'many' deals 'in the hopper' - Yahoo Finance
Trump tariffs live updates: Trump announces UK trade deal with US-China trade talk date set - Yahoo Finance
Trump tariffs live updates: Trump meets with Canada's Carney, hints at coming pharma tariffs - Yahoo Finance
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Trump tariffs live updates: China says 'door is open' to trade talks with the US - Yahoo Finance
US business lobby in China: Some pharma firms reporting tariff exemptions - Yahoo
China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - The AM Reporter
Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines - Yahoo Finance
Is China Pharma Holdings Inc (AMEX: CPHI) A Good Investment For New Investors Now? - Stocksregister
Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy for Long Term Growth? - Yahoo Finance
Pre-market Movers: RGC, SYRS, ADTX, ATXI... - RTTNews
27.81%! LONGi Refreshes the World Record for the Efficiency of Monocrystalline Silicon Cells Again - digitalmore.co
WuXi group wrestles with uncertainty over pharma tariffs - Bamboo Works
Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth? - Yahoo Finance
China Pharma Holdings, Inc. Announces Launch of N95 Medical Protective Mask - marketscreener.com
CPHI stock touches 52-week high of $1.4 amid market fluctuations By Investing.com - Investing.com South Africa
Trump tariffs live updates: Trump reluctant to escalate China tariffs, says 'going to make a deal' - Yahoo Finance
CPHI stock touches 52-week high of $1.4 amid market fluctuations - Investing.com India
China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World
Is Amneal Pharmaceuticals, Inc. (AMRX) the Best Pharma Stock to Buy for Long Term Growth? - Yahoo Finance
Upcoming Stock Splits This Week (April 14 to April 18) – Stay Invested - The Globe and Mail
These Large-Cap Stocks With China And EU Exposure Got Crushed In The One Of The Most Volatile Trading Week (Apr 7-Apr 11): Are These In Your Portfolio?Alibaba Gr Hldgs (NYSE:BABA), Stellantis (NYSE:STLA), PDD Holdings (NASDAQ:PDD) - Benzinga
Will China’s Retaliatory Tariffs Galvanize Manufacturing Onshoring? - insights.citeline.com
China Pharma Stock Set to Reverse Split on Tuesday, April 15th (NYSE:CPHI) - Defense World
CPHI stock touches 52-week low at $0.12 amid market challenges By Investing.com - Investing.com South Africa
CPHI stock touches 52-week low at $0.12 amid market challenges - Investing.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Crude Oil Down 2%; Chanson International Shares Spike Higher - Benzinga
Nasdaq Surges Over 400 Points; China Pharma Shares Plummet - Benzinga
US Stock Futures Slump Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing 'Great Depression-Like' Pattern - Benzinga
US Stock Futures Drop Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing 'Great Depression-Like' Pattern - Benzinga
Levi Strauss, Dave & Buster's Entertainment And 3 Stocks To Watch Heading Into Monday - Benzinga
China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World
China Pharma Announces 1-for-10 Reverse Stock Split - Nasdaq
Bayern Munich's Champions League bid suffers major blow as star man 'is set to be out for TWO MONTHS' - MSN
China Pharma announces 1-for-10 reverse stock split - MSN
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock SplitVietnam Investment Review - Vietnam Investment Review - VIR
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.28%
2.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):